pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
131
view
list
cards
BEYFORTUS
BEYFORTUS (NIRSEVIMAB-ALIP)
1 INDICATIONS AND USAGE BEYFORTUS is indicated for the pr…
$AZN
ASTRAZENECA PLC
Preclinical
BF-844
Usher Syndrome
Case Western Reserve University
Preclinical
BG-22
Solid Tumor
BioStar Pharmaceuticals Inc
Preclinical
← prev
page 66 of 271
next →
Pain
89
Neurology
1
BG-319
Type 1 Diabetes (Juvenile Diabetes)
Bioorg3.14 LLC
Preclinical
BGA-002
Small-Cell Lung Cancer
Biogenera SpA
Phase 2
BGB-16673
Refractory Chronic Lymphocytic Leukemia (CLL)
$ONC
BeOne Medicines Ltd.
Phase 1
BGBB-2033
Metastatic Hepatocellular Carcinoma (HCC)
$ONC
BeOne Medicines Ltd.
Phase 2
BGC-101
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Di…
BiogenCell Ltd
Phase 1
BGC-515
Malignant Mesothelioma
BridGene Biosciences Inc
Preclinical
BGI-9004
Malignant Mesothelioma
BridGene Biosciences Inc
Phase 1
BGM-1812
Obesity
BrightGene Bio-Medical Technology Co Ltd
Preclinical
BGT-DTDS
Neurology
Bloomsbury Genetic Therapies Ltd
Preclinical
BGT-INAD
Neurodegenerative Diseases
Bloomsbury Genetic Therapies Ltd
Preclinical
BGT-NPC
Niemann-Pick Disease Type C
Bloomsbury Genetic Therapies Ltd
Preclinical
BGTF-027
Achromatopsia
Blue Gen Therapeutics Foundation
Phase 1
BH-30236
Refractory Acute Myeloid Leukemia
BlossomHill Therapeutics Inc
Phase 1
BH-3120
Solid Tumor
Hanmi Pharmaceuticals Co Ltd
Phase 2
BHV-1510
Solid Tumor
$BHVN
Biohaven Ltd.
Phase 1
BHV-1530
Glioblastoma Multiforme (GBM)
$BHVN
Biohaven Ltd.
Phase 2
BI-1206
B-Cell Non-Hodgkin Lymphoma
BioInvent International AB
Phase 2
BI-1808
Mycosis Fungoides
BioInvent International AB
Phase 2
BI-1819479
Idiopathic Pulmonary Fibrosis
Boehringer Ingelheim International GmbH
Phase 2
BI-836858
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
Boehringer Ingelheim International GmbH
Preclinical
BICX-101 SR
naltrexone hydrochloride
Alcohol Use Disorder (AUD)
$BICX
BioCorRx Inc.
Preclinical
BICX-102
naltrexone hydrochloride
Alcohol Use Disorder (AUD)
$BICX
BioCorRx Inc.
BIDIL
BIDIL (HYDRALAZINE HYDROCHLORIDE AND ISOSORBIDE DINITRATE)
no indication
AZURITY
Phase 1
BIIB-142
Lupus Nephritis
$BIIB
BIOGEN INC.
BIJUVA
BIJUVA (ESTRADIOL)
no indication
Mayne Pharma Group Ltd
Phase 2
BIMATOPROST
BIMATOPROST
1 INDICATIONS AND USAGE Bimatoprost ophthalmic solution 0…
$AMRX
Amneal Pharmaceuticals, Inc.
Phase 2
BIO-106
Solid Tumor
BiOneCure Therapeutics Inc
